ConforMIS Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
295
- Latest Deal Type
-
M&A
ConforMIS General Information
Description
Conformis Inc is a United States-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
Contact Information
Website
www.conformis.com(Operating Subsidiary)
Corporate Office
- 600 Technology Park Drive
- Billerica, MA 01821
- United States
Corporate Office
- 600 Technology Park Drive
- Billerica, MA 01821
- United States
ConforMIS Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
15. Merger/Acquisition | 05-Sep-2023 | Completed | Generating Revenue/Not Profitable | |||
14. 2PO | 16-Feb-2021 | Completed | Generating Revenue | |||
13. Leveraged Recapitalization | 26-Jun-2019 | Completed | Generating Revenue/Not Profitable | |||
12. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
11. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
10. Secondary Transaction - Open Market | 15-Mar-2017 | Completed | Generating Revenue | |||
9. IPO | 01-Jul-2015 | Completed | Generating Revenue | |||
8. Later Stage VC (Series E) | 05-Aug-2013 | Completed | Generating Revenue | |||
7. Debt - General | 12-Jul-2011 | $1.4M | $122M | Completed | Generating Revenue | |
6. Later Stage VC | 05-Aug-2010 | $10M | $121M | Completed | Generating Revenue |
ConforMIS Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series E2 | ||||||||
Series E1 | ||||||||
Series D | ||||||||
Series C | ||||||||
Series B | 4,469,349 | $0.000010 | $2.69 | $2.69 | 1x | $2.69 | 5.59% | |
Series A | 3,410,278 | $0.000010 | $1 | $1 | 1x | $1 | 4.26% |
ConforMIS Comparisons
Industry
Financing
Details
ConforMIS Competitors (6)
One of ConforMIS’s 6 competitors is BioHorizons, a Formerly PE-Backed company based in Birmingham, AL.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
BioHorizons | Formerly PE-Backed | Birmingham, AL | ||||
Medtronic | Corporation | Minneapolis, MN | ||||
Integra Lifesciences | Corporation | Princeton, NJ | ||||
SeaSpine Holdings | Corporate Backed or Acquired | Carlsbad, CA | ||||
Zimmer Biomet Holdings | Corporation | Warsaw, IN |
ConforMIS Patents
ConforMIS Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20180028325-A1 | Posterior-stabilized knee implants, designs and related methods and tools | Inactive | 17-Sep-2014 | ||
US-20170249440-A1 | 3d printing surgical repair systems | Inactive | 15-Sep-2014 | ||
US-20150250552-A1 | Advanced methods of modeling knee joint kinematics and designing surgical repair systems | Inactive | 08-Feb-2014 | ||
US-10588639-B2 | Spring-fit surgical guides | Active | 23-Jan-2014 | ||
EP-3096693-A1 | Spring-fit surgical guides | Inactive | 23-Jan-2014 | A61B17/15 |
ConforMIS Signals
ConforMIS Former Investors (20)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
AGC Equity Partners | Asset Manager | Minority | ||
Axel Johnson | Holding Company | Minority | ||
Boston Life Science Venture | Venture Capital | Minority | ||
CDIB BioScience Venture Management | Venture Capital | Minority | ||
Calibrium (Zurich) | Family Office | Minority |
ConforMIS Investments & Acquisitions (2)
ConforMIS’s most recent deal was a Merger/Acquisition with Broad Peak Manufacturing for . The deal was made on 09-Aug-2017.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Broad Peak Manufacturing | 09-Aug-2017 | Merger/Acquisition | Therapeutic Devices | ||
Broad Peak Manufacturing (Polishing & Machining Assets) | 09-Aug-2017 | Corporate Asset Purchase | Buildings and Property |
ConforMIS ESG
Risk Overview
Risk Rating
Updated July, 22, 2020
40.02 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,035
Rank
Percentile
Healthcare
Industry
of 521
Rank
Percentile
Medical Devices
Subindustry
of 163
Rank
Percentile
ConforMIS FAQs
-
When was ConforMIS founded?
ConforMIS was founded in 2004.
-
Where is ConforMIS headquartered?
ConforMIS is headquartered in Billerica, MA.
-
What is the size of ConforMIS?
ConforMIS has 295 total employees.
-
What industry is ConforMIS in?
ConforMIS’s primary industry is Other Healthcare Services.
-
Is ConforMIS a private or public company?
ConforMIS is a Private company.
-
What is ConforMIS’s current revenue?
The current revenue for ConforMIS is
. -
How much funding has ConforMIS raised over time?
ConforMIS has raised $460M.
-
Who are ConforMIS’s investors?
AGC Equity Partners, Axel Johnson, Boston Life Science Venture, CDIB BioScience Venture Management, and Calibrium (Zurich) are 5 of 20 investors who have invested in ConforMIS.
-
Who are ConforMIS’s competitors?
BioHorizons, Medtronic, Integra Lifesciences, SeaSpine Holdings, and Zimmer Biomet Holdings are some of the 6 competitors of ConforMIS.
-
When was ConforMIS acquired?
ConforMIS was acquired on 05-Sep-2023.
-
Who acquired ConforMIS?
ConforMIS was acquired by restor3d.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »